MILESTONE PHARMACEUTICALS IN (MIST)

CA59935V1076 - Common Stock

1.54  -0.04 (-2.53%)

After market: 1.58 +0.04 (+2.6%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
1.00M5.00M15.00M0.000.00
Operating Expenses
62.10M64.64M58.07M50.71M57.88M
Research and Development
30.96M39.74M38.67M34.49M41.99M
Selling, General, and Administrative Expenses
31.05M24.81M19.40M16.22M15.90M
Operating Income
-61.10M-59.64M-43.07M-50.71M-57.88M
Interest Income/Expense
1.41M1.25M220.00K730.00K2.60M
Income Before Taxes
-59.69M-58.39M-42.85M-49.98M-55.29M
Income Tax
N/AN/A0.00-20.00K-60.00K
Net Income
-59.69M-58.39M-42.85M-49.97M-55.23M
EBITDA
-61.01M-59.55M-42.98M-50.61M-57.84M
 
Per Share Data
EPS Diluted Total Ops
-1.39-1.38-1.02-1.70-3.50
Non GAAP EPS
-1.39-1.37-1.02-1.73N/A
 
Statistics
Profit Margin
-5968.50%-1167.80%-285.67%N/AN/A
Operating Profit Margin
-6109.80%-1192.80%-287.13%N/AN/A

All data in USD

Charts